You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創機器人-B(02252.HK):R-One™血管介入手術機器人完成NMPA註冊臨牀試驗首例入組
格隆匯 11-25 20:38

格隆匯11月25日丨微創機器人-B(02252.HK)公吿,公司和法國Robocath S.A.S聯合在華成立的合資公司知脈(上海)機器人有限公司(以下簡稱"知脈")引進的R-One血管介入手術機器人完成了在中國的首例機器人輔助經皮冠狀動脈介入治療。這是R-One完成的國家藥品監督管理局("NMPA")註冊臨牀試驗首例入組手術,也標誌着公司在血管介入行業內的又一新的里程碑。

R-One是基於主從控制技術的血管介入導航控制系統,旨在協助心血管介入醫師進行PCI手術,實現精準定位病變,優化球囊和支架導管輸送,使得手術流程標準化、提高手術精確度,同時還可減少手術併發症。此外,使用R-One時,術者可坐在防輻射控制枱後,通過遠端操控,在完成精確手術操作的同時有效減少了在射線下的暴露時間。

R-One首例PCI臨牀試驗是本集團全球化戰略合作中的一個重要里程碑。R-One精準化操作和高效的工作流,將顛覆傳統PCI手術流程,提升病患的安全性,重塑臨牀醫生的工作環境。R-One的臨牀展開和後續上市,將填補國內PCI手術機器人領域的空白,給醫生和患者帶來福音。未來,知脈將實現R-One的本土化生產及裝配,並將參與研發其他血管介入手術機器人系統,開發遠程介入手術和人工智能相關技術。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account